28992-50-9

Basic information

• Product Name: Di(1H-benzo[d][1,2,3]triazol-1-yl)MethaniMine
• Synonyms: Di(1H-benzo[d][1,2,3]triazol-1-yl)MethaniMine;Bis(1H-benzo[d][1,2,3]triazol-1-yl)MethaniMine;alpha-1H-Benzotriazol-1-yl-1H-benzotriazol-1-methanimine;1H-Benzotriazole-1-methanimine, α-1H-benzotriazol-1-yl-
• CAS NO: 28992-50-9
• Molecular Formula: C₁₃H₉N₇
• Molecular Weight: 263.257
• Mol File: 28992-50-9.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Di(1H-benzo[d][1,2,3]triazol-1-yl)MethaniMine(CAS DataBase Reference)
• NIST Chemistry Reference: Di(1H-benzo[d][1,2,3]triazol-1-yl)MethaniMine(28992-50-9)
• EPA Substance Registry System: Di(1H-benzo[d][1,2,3]triazol-1-yl)MethaniMine(28992-50-9)

Safety Data

• Hazardous Substances Data: 28992-50-9(Hazardous Substances Data)

Usage

General Description

Di(1H-benzo[d][1,2,3]triazol-1-yl)MethaniMine, also known as DMBT, is a chemical compound with the molecular formula C7H6N6. DMBT is a 1,2,3-triazole derivative that is commonly used as a corrosion inhibitor in various industrial applications, particularly in the petroleum and natural gas industries. Its unique chemical structure allows it to effectively prevent the corrosion of metals by forming a protective film on their surfaces. Additionally, DMBT is also used as an intermediate in the synthesis of pharmaceutical compounds and in organic chemistry research. Its versatile properties and applications make it an important chemical in various industries.

Upstream product

• 143-33-9 sodium cyanide 
• 21050-95-3 N-chlorobenzotriazole 
• 506-68-3 bromocyane 
• 15217-42-2 sodium benzotriazolate 
• 95-14-7 1,2,3-Benzotriazole 

Relevant articles and documents

HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; (I) wherein R1 R2, R4 and X1 are defeined herein, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

AROMATIC HETEROCYCLIC COMPOUND

The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.

NOVEL TRIAZINE COMPOUNDS

The present invention relates to novel triazine compounds of formula (1), methods of their preparation, pharmaceutical compositions containing these compounds and the use of these compounds to treat proliferative disorders such as tumors and cancers and also other conditions and disorders related to or associated with dysregulation of PI3 Kinases, PI3 Kinase pathway, mTOR and/ or the mTOR pathway.